Literature DB >> 4916538

Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.

N H Bell, S Avery, C C Johnston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4916538     DOI: 10.1210/jcem-31-3-283

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  13 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

Review 2.  Salmon calcitonin: a review of current and future therapeutic indications.

Authors:  C H Chesnut; M Azria; S Silverman; M Engelhardt; M Olson; L Mindeholm
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

Review 3.  Recent progress in calcium metabolism: clinical application.

Authors:  G S Gordan
Journal:  Calif Med       Date:  1971-05

4.  Clinical applications of calcitonin.

Authors: 
Journal:  Can Med Assoc J       Date:  1971-08-07       Impact factor: 8.262

5.  Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.

Authors:  D G Oreopoulos; H Husdan; J Harrison; H E Meema; K G McNeill; T M Murray; R Ogilvie; A Rapoport
Journal:  Can Med Assoc J       Date:  1977-04-23       Impact factor: 8.262

6.  Effect of calcitonin on carrageenan foot oedema.

Authors:  S E Abdullahi; G De Bastiani; L Nogarin; G P Velo
Journal:  Agents Actions       Date:  1975-10

7.  Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.

Authors:  J G Haddad; J G Caldwell
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

8.  The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.

Authors:  F Shai; R K Baker; S Wallach
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

9.  Mithramycin therapy in Paget's disease.

Authors:  A S Russell; B C Lentle
Journal:  Can Med Assoc J       Date:  1974-02-16       Impact factor: 8.262

10.  [Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome].

Authors:  J Pfeilschifter; R Ziegler
Journal:  Med Klin (Munich)       Date:  1998-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.